SUV39H1 Ablation Enhances Long-term CAR T Function in Solid Tumors.

Overview of attention for article published in Cancer Discovery, October 2023

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#23 of 4,163)
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (99th percentile)

Mentioned by

news: 56 news outlets

twitter: 36 X users

Citations

dimensions_citation: 5 Dimensions

Readers on

mendeley: 19 Mendeley

Summary News X Dimensions citations

So far, Altmetric has seen 56 news stories from 56 outlets.

News story from Le Monde on Monday 29 April 2024

Le Monde, 29 Apr 2024

Mnemo Therapeutics Announces Publication in Cancer Discovery on Ablation of SUV39H1 for Long-Term Protection Against Solid Tumors

AP News, 07 Nov 2023

Study shows that ablating the histone methyltransferase SUV39H1 enhances T cell memory/persistence, reduces T cell exhaustion…

Mnemo Therapeutics Announces Publication in Cancer Discovery on Ablation of SUV39H1 for Long-Term Protection Against Solid Tumors

ProfitQuotes.com, 07 Nov 2023

Study shows that ablating the histone methyltransferase SUV39H1 enhances T cell memory/persistence, reduces T cell exhaustion…

Mnemo Therapeutics Announces Publication in Cancer Discovery on Ablation of SUV39H1 for Long-Term Protection Against Solid Tumors

PR Newswire, 07 Nov 2023

Study shows that ablating the histone methyltransferase SUV39H1 enhances T cell memory/persistence, reduces T cell exhaustion…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity, including 52 additional news stories.